171 related articles for article (PubMed ID: 26027772)
1. Primary Sarcomatoid Tumor of the Bladder: A Different Entity but the Same Approach?
Molina-Cerrillo J; Martínez-Sáez O; Alonso-Gordoa T; Tirado-Zambrano P; Delgado-Vargas B; Earl J; Grande E
Clin Genitourin Cancer; 2015 Dec; 13(6):493-8. PubMed ID: 26027772
[TBL] [Abstract][Full Text] [Related]
2. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
Sanfrancesco J; McKenney JK; Leivo MZ; Gupta S; Elson P; Hansel DE
Arch Pathol Lab Med; 2016 Jun; 140(6):543-51. PubMed ID: 27031776
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
4. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Sep; 37(9):573.e19-573.e29. PubMed ID: 31358384
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases.
Urrea YR; Epstein JI
Hum Pathol; 2017 Sep; 67():169-175. PubMed ID: 28827101
[TBL] [Abstract][Full Text] [Related]
7. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
Black PC; Brown GA; Dinney CP
Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
[TBL] [Abstract][Full Text] [Related]
8. Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.
Krishnamurthy K; Rosen S; Ye H; Sun Y
Ann Diagn Pathol; 2022 Jun; 58():151923. PubMed ID: 35180608
[TBL] [Abstract][Full Text] [Related]
9. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
10. Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
Tajima S; Suzuki T; Yamada Y; Morikawa T; Minagawa D; Homma Y; Fukayama M
Med Mol Morphol; 2016 Sep; 49(3):182-7. PubMed ID: 25690253
[TBL] [Abstract][Full Text] [Related]
11. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
12. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
Fatima N; Osunkoya AO
Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
Bansal A; Kumar N; Sharma SC
J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698
[TBL] [Abstract][Full Text] [Related]
14. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
15. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
16. Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach.
Genheimer CW; Guthrie KI; Shokes JE; Bruce AT; Quinlan SF; Sangha N; Ilagan RM; Basu J; Burnette T; Ludlow JW
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):184-9. PubMed ID: 20930617
[TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
18. Clear cell urothelial carcinoma of the urinary bladder - a rare pathological entity. A case report and a systematic review of the literature.
Mihai I; Taban S; Cumpanas A; Olteanu EG; Iacob M; Dema A
Bosn J Basic Med Sci; 2019 Nov; 19(4):400-403. PubMed ID: 30957722
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
[TBL] [Abstract][Full Text] [Related]
20. Variant forms of bladder cancer: basic considerations on treatment approaches.
Pons F; Orsola A; Morote J; Bellmunt J
Curr Oncol Rep; 2011 Jun; 13(3):216-21. PubMed ID: 21360040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
